SCHEMBL26883118

SCHEMBL26883118

CC(=O)OC1C(O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@H]1n1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 2/20 0.65
▸ TAS1R1 Q7RTX1 2/20 0.65
▸ TGM2 P21980 1/20 0.65
▸ KRAS P01116 2/20 0.64
▸ FUT5 Q11128 1/20 0.63
▸ RNASEL Q05823 4/20 0.61
▸ NT5E P21589 1/20 0.61
▸ P2RY6 Q15077 2/20 0.60
▸ P2RY2 P41231 1/20 0.60
▸ P2RY4 P51582 1/20 0.60
▸ P2RY11 Q96G91 3/20 0.58
▸ P2RX3 P56373 3/20 0.56
▸ ENPP1 P22413 2/20 0.56
▸ P2RY1 P47900 2/20 0.56
▸ P2RX1 P51575 2/20 0.56
▸ P2RX4 Q99571 2/20 0.56
▸ DCPS Q96C86 1/20 0.56
▸ P2RY12 Q9H244 1/20 0.55
▸ P2RX6 O15547 1/20 0.55
▸ P2RX5 Q93086 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26632570 1.00 TAS1R3 (0.65) TAS1R3TAS1R1TGM2KRASFUT5
SCHEMBL26632575 1.00 TAS1R3 (0.65) TAS1R3TAS1R1TGM2KRASFUT5
SCHEMBL26882941 1.00 TAS1R3 (0.65) TAS1R3TAS1R1TGM2KRASFUT5
SCHEMBL31724981 0.99 TAS1R3 (0.66) TAS1R3TAS1R1TGM2KRASFUT5
SCHEMBL31725233 0.93 TAS1R3 (0.74) TAS1R3TAS1R1TGM2KRASFUT5
SCHEMBL18503529 0.92 TGM2 (0.58) TAS1R3TAS1R1TGM2KRASFUT5
SCHEMBL17198456 0.92 TGM2 (0.58) TAS1R3TAS1R1TGM2KRASFUT5
SCHEMBL26882725 0.91 RNASEL (0.60) TAS1R3TAS1R1TGM2KRASFUT5
SCHEMBL23149534 0.91 TGM2 (0.68) TAS1R3TAS1R1TGM2KRASFUT5
SCHEMBL15747230 0.91 TGM2 (0.68) TAS1R3TAS1R1TGM2KRASFUT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230383287-A1 ACETYLATED RIBONUCLEIC ACIDS AND USES THEREOF HELIX NANOTECHNOLOGIES INC 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230383287-A1 ACETYLATED RIBONUCLEIC ACIDS AND USES THEREOF NSUN2, NSUN3, ADAR TAS1R3 3515/4885TAS1R1 3915/4885TGM2 1985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback